Production (Stage)
Ensysce Biosciences, Inc.
ENSC
$2.07
-$0.07-3.27%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.05M | 3.50M | 4.15M | 1.04M | 3.40M |
| Total Receivables | 22.00K | 124.10K | 1.78M | 224.20K | 96.20K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 338.60K | 358.00K | 483.30K | 588.70K | 403.30K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 987.90K | 1.36M | 2.67M | 603.60K | 792.70K |
| Total Current Assets | 4.40M | 5.34M | 9.09M | 2.46M | 4.70M |
|
|
|||||
| Total Current Assets | 4.40M | 5.34M | 9.09M | 2.46M | 4.70M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 210.90K | 252.60K | 294.20K | 335.90K | 377.60K |
| Total Assets | 4.61M | 5.60M | 9.38M | 2.80M | 5.07M |
|
|
|||||
| Total Accounts Payable | 615.30K | 1.36M | 1.97M | 482.00K | 981.70K |
| Total Accrued Expenses | 888.50K | 548.50K | 447.00K | 370.20K | 408.40K |
| Short-term Debt | 257.40K | 301.70K | 387.20K | 454.50K | 246.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.76M | 2.21M | 2.80M | 1.31M | 1.64M |
|
|
|||||
| Total Current Liabilities | 1.76M | 2.21M | 2.80M | 1.31M | 1.64M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 257.40K | 301.70K | 387.20K | 454.50K | 246.00K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 130.20K | 10.10K | 3.20K | 9.60K | 17.40K |
| Total Liabilities | 1.89M | 2.22M | 2.81M | 1.32M | 1.65M |
|
|
|||||
| Common Stock & APIC | 134.54M | 133.25M | 132.89M | 128.45M | 128.42M |
| Retained Earnings | -131.49M | -129.54M | -125.98M | -126.64M | -124.67M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 3.05M | 3.71M | 6.91M | 1.81M | 3.75M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.05M | 3.71M | 6.91M | 1.81M | 3.75M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -328.50K | -328.50K | -328.50K | -328.50K | -328.50K |
| Total Equity | 2.72M | 3.38M | 6.58M | 1.48M | 3.42M |
|
|
|||||